Last week the share price of Aussie biotech company Starpharma jumped 23% in one day, after very positive interim clinical trial results for its new cancer treatment.

Dr Jackie Fairley, CEO of Starpharma, talks to Jennifer Duke about the test results, the process in bringing treatments to market, and the challenges and rewards of leading a biotech company working on life-changing research.

This is general information only. You should seek professional advice before making investment decisions.